BeOne Medicines AG (FRA:49BA)

Germany · Delayed Price · Currency is EUR

290.00

+4.00 (1.40%)

At close: Jan 29, 2026

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013
U.S. Revenue	2.64B	1.96B
China Revenue	1.64B	1.41B
Europe Revenue	552.63M	362.63M
Rest of World Revenue	149.15M	78.81M
Revenue (Total)	4.97B	3.81B

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013
BRUKINSA Revenue	3.61B	2.64B
TEVIMBRA Revenue	709.11M	620.84M
XGEVA Revenue	298.51M	224.40M
BLINCYTO Revenue	100.59M	74.33M
KYPROLIS Revenue	75.67M	66.17M
POBEVCY Revenue	48.60M	53.51M
REVLIMID Revenue	-	36.03M
Other Product Revenue	-	60.04M
Total Other Product Revenue	80.96M	96.07M
Total Product Revenue	4.92B	3.78B
Collaboration Revenue	49.03M	30.70M
Revenue (Total)	4.97B	3.81B

Updated Sep 30, 2025. Data Source: Fiscal.ai.